Multicenter, Open Label, Phase II Trial to Evaluate the Efficacy and Safety of Treatment With Rituximab + CHOP Regimen in Patients With HIV Related Non-Hodgkin's Lymphomas. ANRS 085 Rituximab
Sponsor study identifier
interventional
60
1 country
1
Study Start
January 1999
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
October 2003
Date type not reportedThis date has not been verified as actual or estimated.
Most treatment procedures in AIDS-related lymphomas disclose a relatively poor outcome for patients with low response rates, high number of relapses and AIDS events. The addition of rituximab to the standard regimen - CHOP could improve the outcome of these patients. The aim of the trial is to evaluate the safety and efficacy of rituximab when added to the CHOP regimen in patients with newly diagnosed AIDS-related non-Hodgkin lymphoma.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
October 2003
Date type not reportedThis date has not been verified as actual or estimated.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 1999
Date type not reportedThis date has not been verified as actual or estimated.
October 2003
Date type not reportedThis date has not been verified as actual or estimated.
August 2, 2005
Actual (reported)August 3, 2005
Actual (reported)Evaluate the response rate of lymphoma treated
Duration of response
Evaluate the time to progression
Survival
Safety of rituximab in HIV patients with lymphoma when sequentially administered with chemotherapy
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Service de Medecine Interne Hopital Antoine Beclere
Clamart, 92140, France
Francois Boue, MD
Service de Medecine Interne Hopital A Beclere Clamart France
Dominique Costagliola
Inserm U 720
First Submitted
August 2, 2005
First Posted
August 3, 2005
Study Start
January 1999
Date type not reportedThis date has not been verified as actual or estimated.
Study Completion
October 2003
Date type not reportedContact the study team to confirm eligibility.
This date has not been verified as actual or estimated.
Last Updated
August 17, 2005
Record last verified: 2005-08
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: